Open Question

Does automated volumetric response assessment change trial conclusions or clinical decisions versus bidimensional RANO?

Evidence profile

Status: question. Rule: atlas-profile-2.0.

4 linked publications; not a count of independent studies.

Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.

Historical grade: MODERATE (retained from 22 September 2026; not a completed profile 2.0 assessment).

Why it matters

Segmentation is near-solved technically, but whether volumetrics actually alter response classification and outcomes is unproven; effort has outpaced evidence of value.

Conflicting evidence

BraTS-driven segmentation is robust, but volumetric RANO is not standard and marginal Dice gains lack demonstrated clinical translation.

Proposed study direction

Re-analyze completed trials with automated volumetrics vs bidimensional RANO; test whether response category and hazard estimates change.

Prepare a research brief

Gap verification

This question comes from selected literature. Confirm that the gap remains open with a current search and mentor review.

Open in the interactive atlas →

About this page

Curated and maintained by Resonant Labs. Editorial lead: Claims are synthesized from the cited literature and graded per the Atlas methodology (about the Atlas). Page generated 2026-10-02. This is not a new clinical review date.

This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.